Funding Freeze: Victoria’s Research Sector on Brink of Collapse

The Hudson Institute of Medical Research, a 66-year-old institution in Australia’s scientific landscape, faces an existential crisis. It will cease operating independently and be absorbed into Monash University, resulting in the loss of at least 75 jobs. This is not just a local tragedy; it’s a symptom of a wider problem plaguing Victoria’s research sector.

Funding for medical research has been declining for years. Australia’s spending on R&D as a percentage of GDP has shrunk since the early 2000s, while key government agencies have seen their budgets flatline or shrink over the same period. In contrast, other advanced economies have increased their investments in science, rendering Australia’s relative position increasingly precarious.

The Hudson Institute is hardly unique in its situation. Ten of Victoria’s 14 independent research institutes are forecasted to close by 2030, according to the Association of Australian Medical Research Institutes (AAMRI). These institutions drive innovation and advance our understanding of diseases such as cancer and Alzheimer’s. Without sustained support, they will be forced to downsize or close altogether.

The federal government grant for a single cancer research project covers less than half the cost of conducting that research. Institutes must rely on philanthropy, commercial activities, or state governments to make up the shortfall – a precarious balancing act at best. Dr Saraid Billiards, CEO of AAMRI, notes, “If there is no change at federal or state level, 10 of the 14 institutes are forecasted to close their doors by 2030.”

The National Ageing Research Institute in Parkville is another casualty of this funding drought. Despite being a leader in ageing-related research and housing the country’s largest collection of aged care cell lines, it faces significant financial pressures. “We’re solvent,” admits Chief Executive Professor Tracy Comans, “but we’re running deficits year in, year out.” Without fundamental reform to the funding scheme, the institute cannot sustain itself indefinitely.

Mergers with universities have been touted as a solution, but this is not always a viable option. Burnet Institute’s director, Professor Brendan Crabb, cautions that such moves can lead to “invisible” research, where institutes lose their independence and distinct focus. Crabb advocates for increased state government funding – doubling the current level of $50 million per year would be a good starting point.

The Victorian Minister for Medical Research, Anthony Carbines, has a crucial role to play in addressing this crisis. He must work with his federal counterparts to ensure that medical research receives adequate support. As Crabb puts it, “I don’t see another way in the immediate to fix this issue.”

In the short term, the closure of the Hudson Institute and other institutes will have a direct impact on staff, who face an uncertain future. In the long term, however, the consequences are far more profound. The collapse of Victoria’s research sector would damage Australia’s reputation as a hub for medical innovation and undermine the foundations of our healthcare system.

The situation demands urgent attention from policymakers. If left unchecked, the consequences will be severe, with far-reaching implications for the country’s scientific landscape and its citizens’ health.